GBIO – generation bio co. - common stock (US:NASDAQ)

News

Generation Bio (NASDAQ:GBIO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Generation Bio Announces Third Quarter 2025 Financial Results
Generation Bio Announces CEO Transition
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com